CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the priority to Korean Patent Application No. 10-2014-0015645, filed on Feb. 11, 2014, and all the benefits accruing therefrom under 35 U.S.C. §119, the content of which is incorporated herein in its entirety by reference.

BACKGROUND

1. Field

One or more embodiments of the present disclosure relate to a carbazole-based compound and an organic light-emitting device including the carbazole-based compound.

2. Description of the Related Art

Organic light-emitting devices (OLEDs), which are self-emitting devices, have advantages such as wide viewing angles, excellent contrast ratios, and quick response times. In addition, OLEDs exhibit high brightness, excellent driving voltage characteristics, and can provide multicolored images.

A typical organic light-emitting device may include an anode, a cathode, and an emission layer disposed between the anode and the cathode. The organic light-emitting device may include a hole transport region between the anode and the emission layer, and an electron transport region between the emission layer and the cathode. Holes injected from the anode move to the emission layer via the hole transport region, while electrons injected from the cathode move to the emission layer via the electron transport region. Carriers such as the holes and electrons recombine in the emission layer to generate excitons. When the excitons drop from an excited state to a ground state, light is emitted.

Various types of organic light emitting devices are known. However, there still remains a need in OLEDs having low driving voltage, high efficiency, high brightness, and long lifespan.

SUMMARY

One or more embodiments of the present disclosure include a novel carbazole-based compound, and an organic light-emitting device including the same.

Additional aspects will be set forth in part in the description which follows and, in part, will be apparent from the description, or may be learned by practice of the presented embodiments.

According to one or more embodiments, a carbazole-based compound represented by Formula 1A or 1B is provided:

embedded image

wherein, in Formulae 1A and 1B,

ring A is a C₂-C₂₀heterocyclic group including at least two nitrogens as ring-forming atoms and is a 6-membered ring, a 6-membered ring to which a 6-membered ring is condensed, or a 6-membered ring to which a 5-membered ring is condensed;

L₁, L₂, L₁₁, and L₁₂are each independently selected from a substituted or unsubstituted C₃-C₁₀cycloalkylene group, a substituted or unsubstituted C₂-C₁₀heterocycloalkylene group, a substituted or unsubstituted C₃-C₁₀cycloalkenylene group, a substituted or unsubstituted C₂-C₁₀heterocycloalkenylene group, a substituted or unsubstituted C₆-C₆₀arylene group, a substituted or unsubstituted C₂-C₆₀heteroarylene group, a substituted or unsubstituted divalent nonaromatic condensed polycyclic group, and a substituted or unsubstituted divalent nonaromatic condensed heteropolycyclic group;

a1, a2, a3, and a4 are each independently an integer selected from 0 to 3;

R₁to R₉, and R₁₁to R₁₈are each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C₁-C₆₀alkyl group, a substituted or unsubstituted C₂-C₆₀alkenyl group, a substituted or unsubstituted C₂-C₆₀alkynyl group, a substituted or unsubstituted C₁-C₆₀alkoxy group, a substituted or unsubstituted C₃-C₁₀cycloalkyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₆-C₆₀aryloxy group, a substituted or unsubstituted C₆-C₆₀arylthio group, a substituted or unsubstituted C₂-C₆₀heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group, and —Si(Q₁)(Q₂)(Q₃); and

b1, b2, and b3 are each independently an integer selected from 1 to 5, wherein at least one of R₅to R₈is selected from a substituted or unsubstituted C₃-C₁₀cycloalkyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₆-C₆₀aryloxy group, a substituted or unsubstituted C₆-C₆₀arylthio group, a substituted or unsubstituted C₂-C₆₀heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, and a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group;

at least one substituent of the substituted C₃-C₁₀cycloalkenylene group, the substituted C₂-C₁₀heterocycloalkenylene group, the substituted C₆-C₆₀arylene group, the substituted C₂-C₆₀heteroarylene group, the substituted divalent nonaromatic condensed polycyclic group, the substituted divalent nonaromatic condensed heteropolycyclic group, the substituted C₁-C₆₀alkyl group, the substituted C₂-C₆₀alkenyl group, the substituted C₂-C₆₀alkynyl group, the substituted C₃-C₁₀cycloalkyl group, the substituted C₂-C₁₀heterocycloalkyl group, the substituted C₃-C₁₀cycloalkenyl group, the substituted C₂-C₁₀heterocycloalkenyl group, the substituted C₆-C₆₀aryl group, the substituted C₆-C₆₀aryloxy group, the substituted C₆-C₆₀arylthio group, the substituted C₂-C₆₀heteroaryl group, the substituted monovalent nonaromatic condensed polycyclic group, and the substituted monovalent nonaromatic condensed heteropolycyclic group is selected from

a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, and a C₁-C₆₀alkoxy group, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, and a C₁-C₆₀alkoxy group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₃-C₁₀cycloalkyl group, a C₂-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₂-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₂-C₆₀heteroaryl group, a monovalent nonaromatic condensed polycyclic group, a monovalent nonaromatic condensed heteropolycyclic group, —Si(Q₁₁)(Q₁₂)(Q₁₃), and —B(Q₁₄)(Q₁₅),

a C₃-C₁₀cycloalkyl group, a C₂-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₂-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₂-C₆₀heteroaryl group, a monovalent nonaromatic condensed polycyclic group, and a monovalent nonaromatic condensed heteropolycyclic group; a C₃-C₁₀cycloalkyl group, a C₂-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₂-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₂-C₆₀heteroaryl group, a monovalent nonaromatic condensed polycyclic group, and a monovalent nonaromatic condensed heteropolycyclic group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₂-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₂-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₂-C₆₀heteroaryl group, a monovalent nonaromatic condensed polycyclic group, a monovalent nonaromatic condensed heteropolycyclic group, —Si(Q₂₁)(Q₂₂)(Q₂₃), and —B(Q₂₄)(Q₂₅), and

—Si(Q₃₁)(Q₃₂)(Q₃₃), and —B(Q₃₄)(Q₃₅);

wherein Q₁to Q₃, Q₁₁to Q₁₅, Q₂₁to Q₂₅, and Q₃₁to Q₃₅are each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₂-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₂-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₂-C₆₀heteroaryl group, a monovalent nonaromatic condensed polycyclic group, and a monovalent nonaromatic condensed heteropolycyclic group.

According to one or more embodiments of the present disclosure, an organic light-emitting device includes:

a first electrode;

a second electrode; and

an organic layer disposed between the first electrode and the second electrode, wherein the organic layer includes an emission layer and at least one of the carbazole-based compounds.

BRIEF DESCRIPTION OF THE DRAWINGS

These and/or other aspects will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings in which:

FIG. 1 is a schematic view of an organic light-emitting device according to an embodiment of the present disclosure.

DETAILED DESCRIPTION

Reference will now be made in detail to embodiments, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to the like elements throughout. In this regard, the present embodiments may have different forms and should not be construed as being limited to the descriptions set forth herein. Accordingly, the embodiments are merely described below, by referring to the figures, to explain aspects of the present description. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items. Expressions such as “at least one of,” when preceding a list of elements, modify the entire list of elements and do not modify the individual elements of the list.

It will be understood that when an element is referred to as being “on” another element, it can be directly in contact with the other element or intervening elements may be present therebetween. In contrast, when an element is referred to as being “directly on” another element, there are no intervening elements present.

It will be understood that, although the terms first, second, third etc. may be used herein to describe various elements, components, regions, layers, and/or sections, these elements, components, regions, layers, and/or sections should not be limited by these terms. These terms are only used to distinguish one element, component, region, layer, or section from another element, component, region, layer, or section. Thus, a first element, component, region, layer, or section discussed below could be termed a second element, component, region, layer, or section without departing from the teachings of the present embodiments.

The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting. As used herein, the singular forms “a,” “an,” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise.

The term “or” means “and/or.” It will be further understood that the terms “comprises” and/or “comprising,” or “includes” and/or “including” when used in this specification, specify the presence of stated features, regions, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, regions, integers, steps, operations, elements, components, and/or groups thereof.

Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this general inventive concept belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and the present disclosure, and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.

Exemplary embodiments are described herein with reference to cross section illustrations that are schematic illustrations of idealized embodiments. As such, variations from the shapes of the illustrations as a result, for example, of manufacturing techniques and/or tolerances, are to be expected. Thus, embodiments described herein should not be construed as limited to the particular shapes of regions as illustrated herein but are to include deviations in shapes that result, for example, from manufacturing. For example, a region illustrated or described as flat may, typically, have rough and/or nonlinear features. Moreover, sharp angles that are illustrated may be rounded. Thus, the regions illustrated in the figures are schematic in nature and their shapes are not intended to illustrate the precise shape of a region and are not intended to limit the scope of the present claims.

According to an embodiment of the present disclosure, there is provided a carbazole-based compound represented by Formula 1A or 1B:

embedded image

In Formulae 1A and 1B, ring A may be a C₂-C₂₀heterocyclic group including at least two nitrogens (N) as ring-forming atoms and is a 6-membered ring, a 6-membered ring to which a 6-membered ring is condensed, or a 6-membered ring to which a 5-membered ring is condensed.

For example, in Formulae 1A and 1B, ring A may be a C₂-C₂₀heterocyclic group including at least three nitrogens as ring-forming atoms.

For example, in Formulae 1A and 1B, the ring A may be selected from groups represented by Formulae 2-1 to 2-8, but is not limited thereto:

embedded image

In Formulae 2-1 to 2-8,

R_9ato R_9emay be the same or different, and each may have the same definition as R₉to be described below, and

* indicates a binding site to an adjacent atom.

For example, the ring A in Formula 1A or 1B may be a group represented by one of Formulae 2-1, 2-5, and 2-8, but is not limited thereto.

Also, for example, the ring A in Formula 1A or 1B may be a group represented by one of Formulae 2-1 to 2-4, but is not limited thereto.

In Formulae 1A and 1B, L₁, L₂, L₁₁, and L₁₂may be each independently selected from a substituted or unsubstituted C₃-C₁₀cycloalkylene group, a substituted or unsubstituted C₂-C₁₀heterocycloalkylene group, a substituted or unsubstituted C₃-C₁₀cycloalkenylene group, a substituted or unsubstituted C₂-C₁₀heterocycloalkenylene group, a substituted or unsubstituted C₆-C₆₀arylene group, a substituted or unsubstituted C₂-C₆₀heteroarylene group, a substituted or unsubstituted divalent nonaromatic condensed polycyclic group, and a substituted or unsubstituted divalent nonaromatic condensed heteropolycyclic group.

For example, in Formulae 1A and 1B, L₁, L₂, L₁₁, and L₁₂may be each independently selected from:

a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-fluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pyrrolylene group, an imidazolylene group, a pyrazolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, an indazolylene group, a purinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a carbazolylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzooxazolylene group, a benzoimidazolylene group, a furanylene group, a benzofuranylene group, a thiophenylene group, a benzothiophenylene group, a thiazolylene group, an isothiazolylene group, a benzothiazolylene group, an isoxazolylene group, an oxazolylene group, a triazolylene group, a tetrazolylene group, an oxadiazolylene group, a triazinylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, an imidazopyrimidinylene group, and an imidazopyridinylene group, and

a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-fluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pyrrolylene group, an imidazolylene group, a pyrazolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, an indazolylene group, a purinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a carbazolylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzooxazolylene group, a benzoimidazolylene group, a furanylene group, a benzofuranylene group, a thiophenylene group, a benzothiophenylene group, a thiazolylene group, an isothiazolylene group, a benzothiazolylene group, an isoxazolylene group, an oxazolylene group, a triazolylene group, a tetrazolylene group, an oxadiazolylene group, a triazinylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, an imidazopyrimidinylene group, and an imidazopyridinylene group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a C₆-C₂₀aryl group, and a C₂-C₆₀heteroaryl group, and

groups represented by Formulae 3-1 to 3-6.

embedded image

In Formulae 3-1 to 3-6, Z₁₁to Z₁₆are each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a C₆-C₂₀aryl group, and a C₂-C₆₀heteroaryl group; and

* and *′ each indicate a binding site to an adjacent atom.

In some embodiments, in Formulae 1A and 1B, L₁, L₂, L₁₁, and L₁₂may be each independently selected from, but not limited to,

a phenylene group, a naphthylene group, a phenalenylene group, a phenanthrenylene group, a triphenylenylene group, an anthracenylene group, a pyrrolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, a furanylene group, a benzofuranylene group, a thiophenylene group, a benzothiophenylene group, and a triazinylene group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a triphenylenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group, and

groups represented by Formulae 3-1 to 3-6.

In Formulae 3-1 to 3-6, Z₁₁to Z₁₆may be each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a triphenylenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group.

For example, in Formulae 1A and 1B, L₁, L₂, L₁₁, and L₁₂may be each independently selected from groups represented by Formulae 4-1 to 4-15, and Formulae 3-1 to 3-6, but are not limited thereto:

embedded image

In Formula 1A, a1, which indicates the number of groups L₁, may be an integer selected from 0 to 3. For example, a1 may be 0, 1, or 2. When a1 is 0, R₁may be directly linked to the nitrogen atom (N) of the carbazole ring. When a1 is 2 or greater, the two or more groups L₁may be identical to or different from each other. Variables a2, a3, and a4 may be understood based on the description of a1 and the structures of Formulae 1A and 1B.

In Formulae 1A and 1B, a1, a2, a3, and a4 may be each independently 0, 1, or 2, but are not limited thereto.

In Formulae 1A and 1B, R₁to R₉, and R₁₁to R₁₈may be each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C₁-C₆₀alkyl group, a substituted or unsubstituted C₂-C₆₀alkenyl group, a substituted or unsubstituted C₂-C₆₀alkynyl group alkynyl group, a substituted or unsubstituted or unsubstituted C₁-C₆₀alkoxy group, a substituted or unsubstituted C₃-C₁₀cycloalkyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₆-C₆₀aryloxy group, a substituted or unsubstituted C₆-C₆₀arylthio group, a substituted or unsubstituted C₂-C₆₀heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group, and —Si(Q₁)(Q₂)(Q₃).

For example, in Formulae 1A and 1B,

R₁and R₁₁may be each independently selected from a substituted or unsubstituted C₆-C₂₀aryl group, a substituted or unsubstituted C₂-C₂₀heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group, and —Si(Q₁)(Q₂)(Q₃);

R₂to R₉, and R₁₂to R₁₈may be each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C₁-C₂₀alkyl group, a substituted or unsubstituted C₁-C₂₀alkoxy group, a substituted or unsubstituted C₃-C₁₀cycloalkyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₂₀aryl group, a substituted or unsubstituted C₂-C₂₀heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group, and —Si(Q₁)(Q₂)(Q₃); wherein

at least one of R₅to R₈may be selected from a substituted or unsubstituted C₆-C₂₀aryl group, a substituted or unsubstituted C₂-C₂₀heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, and a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group.

In some embodiments, in Formulae 1A and 1B,

R₁to R₉, and R₁₁to R₁₈may be each independently selected from:

a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyrimidinyl group, and an imidazopyridinyl group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₂-C₂₀alkenyl group, a C₂-C₂₀alkynyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group, and

—Si(Q₁)(Q₂)(Q₃); wherein at least one of R₅to R₈may be selected from:

R₁and R₁₁may be each independently selected from, but not limited to,

—Si(Q₁)(Q₂)(Q₃),

wherein Q₁to Q₃are each independently selected from a hydrogen, C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a triphenylenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group.

In some embodiments, in Formulae 1A and 1B,

R₁and R₁₁may be each independently selected from groups represented by Formulae 5-1 to 5-40, and —Si(Q₁)(Q₂)(Q₃), wherein Q₁to Q₃may be each independently selected from a hydrogen, C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a triphenylenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group;

R₂to R₄, and R₁₁to R₁₄may be each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, and a C₁-C₂₀alkoxy group;

R₅to R₉, and R₁₅to R₁₈may be each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, and groups represented by Formulae 5-1 to 5-40; wherein

at least one of R₅to R₈, and at least one of R₁₅to R₁₈may be each independently selected from groups represented by Formulae 5-1 to 5-40; and

at least one of groups R₉is selected from groups represented by Formulae 5-1 to 5-40. However, embodiments of the present disclosure are not limited thereto.

embedded image

In Formulae 5-1 to 5-40,

Z₁to Z₃may be each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₂-C₂₀alkenyl group, a C₂-C₂₀alkynyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group;

d1 may be 1 or 2;

- d2 may be an integer selected from 1 to 3;
- d3 may be an integer selected from 1 to 4;
- d4 may be an integer selected from 1 to 5;
- d5 may be an integer selected from 1 to 6;
- d6 may be an integer selected from 1 to 7;
- d7 may be an integer selected from 1 to 8; and

d8 may be an integer selected from 1 to 9;

* indicates a binding site to an adjacent atom.

In some embodiments, in Formulae 1A and 1B, R₁to R₈, and R₁₁to R₁₈may be each independently selected from:

a C₁-C₂₀alkyl group and a C₁-C₂₀alkoxy group, each substituted with at least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, and a phosphoric acid group or a salt thereof,

a phenyl group, a naphthyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a phenanthrenyl group, a phenylenyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a phenylenyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, and

—Si(Q₁)(Q₂)(Q₃), wherein Q₁to Q₃may be each independently selected from a hydrogen, C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a triphenylenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group; wherein

at least one of R₅to R₈, and at least one of R₁₅to R₁₈may be each independently selected from, but not limited to,

In Formulae 1A and 1B, b1, which indicates the number of substituents R₁, may be an integer selected from 1 to 5. For example, b1 may be 1 or 2.

In Formulae 1A and 1B, b2, which indicates the number of substituents R₉, may be an integer selected from 1 to 5. For example, b2 may be 1 or 2.

In Formulae 1A and 1B, b3, which indicates the number of substituents R₁₁, may be an integer selected from 1 to 5. For example, b3 may be 1 or 2.

In some embodiments, at least one of substituents R₉may be selected from a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₂-C₆₀heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, and a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group.

For example, at least one of R_9aand R_9bin Formula 2-1, at least one of R_9ato R_9cin Formulae 2-2 to 2-5, and 2-8, and at least one of R_9ato R_9ein Formulae 2-6, 2-7, and 2-9 to 2-16 may be selected from a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₂-C₆₀heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, and a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group.

For example, in Formulae 1A and 1B, each of b1, b2, and b3 may be 1. However, embodiments of the present disclosure are not limited thereto.

For example, in Formula 1B, L₁=L₁₁, L₂=L₁₂, a1=a3, a2=a4, R₁=R₁₁, R₂=R₁₂, R₃=R₁₃, R₄=R₁₄, R₅=R₁₅, R₆=R₁₆, R₇=R₁₇, R₈=R₁₈, and b1=b3. However, embodiments of the present disclosure are not limited thereto.

In some embodiments, the carbazole-based compound may be represented by Formula 1A in which

a1 is 0;

R₁is selected from Formulae 5-1 to 5-40 (for example, R₁may be represented by Formula 5-1);

b1 is 0;

R₂to R₆and R₈are a hydrogen;

R₇is selected from Formulae 5-1 to 5-40 (for example, R₇may be represented by Formula 5-40); a2 is 0 or 1;

L₂is selected from Formulae 4-1 to 4-15 (for example, L₂may be represented by Formula 4-2);

ring A is represented Formula 2-1 (wherein, in Formula 2-1, R_9aand R_9bmay be each independently, selected from Formulae 5-1 to 5-40, and, for example, R_9aand R_9bmay be represented by Formula 5-1).

In other embodiments, the carbazole-based compound may be represented by Formula 1A in which

a1 is 0;

R₁is represented by Formula 5-1;

b1 is 0;

R₂to R₆and R₈are a hydrogen;

R₇is represented by Formula 5-40; a2 is 0 or 1;

L₂is represented by Formula 4-2;

ring A is represented Formula 2-1 (wherein, in Formula 2-1, R_9aand R_9bis represented by Formula 5-1).

In some embodiments, the carbazole-based compound of Formula 1A or 1B may be one of Compounds 1 to 130.

embedded image

For example, in Formulae 1A and 1B, at least one of R₅to R₈may be selected from a substituted or unsubstituted C₃-C₁₀cycloalkyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₆-C₆₀aryloxy group, a substituted or unsubstituted C₆-C₆₀arylthio group, a substituted or unsubstituted C₂-C₆₀heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, and a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group. This may provide an enhanced steric hindrance effect to the carbazole-based compound of Formula 1A or 1B, and consequently suppress agglomeration of the carbazole-based compound. Thus, an organic light-emitting device including the carbazole-based compound of Formula 1A or 1B may have improved emission efficiency.

The carbazole-based compound of Formula 1A or 1B includes a “carbazole-based ring” (see Formula 1A′), and thus may have an energy band gap suitable for use as a material of an organic light-emitting device (for example, a host material of an emission layer).

embedded image

The carbazole-based compound of Formula 1A or 1B does not include an amino group and a derivative thereof. An amino group and a derivative thereof may have poor thermal stability and poor electrical stability against migration of electrons, and may hinder controlling an energy level of the carbazole-based compound for use as a host material of an organic light-emitting device, and consequentially lower emission efficiency of the organic light-emitting device. However, the carbazole-based compound of Formula 1A or 1B is designed to exclude “an amino group and a derivative thereof” in molecules, and thus may have an energy band gap range appropriate for use as a material (for example, a host material of an emission layer) of an organic light-emitting device.

Furthermore, “the ring A” in the carbazole-based compound of Formula 1A or 1B is linked to a “fourth carbon” (refer to Formula 1A′) of the carbazole-based ring in Formulae 1A and 1B, so that a highest occupied molecular orbital (HOMO) region and a lowest unoccupied molecular orbital (LUMO) region may be effectively separated from each other in the carbazole-based compound of Formula 1A or 1B. Thus, the carbazole-based compound of Formula 1A or 1b may have a high triplet (T1) energy level.

A synthesis method of the carbazole-based compound of Formula 1A or 1B may be understood by those of ordinary skill in the art based on synthesis examples to be described below.

The carbazole-based compound of Formula 1A or 1B is suitable for use in an organic layer, for example, as a host in an emission layer of an organic light-emitting device. According to another embodiment of the present disclosure, an organic light-emitting device includes

a first electrode,

a second electrode, and

an organic layer disposed between the first electrode and the second electrode,

wherein the organic layer includes an emission layer and at least one of the carbazole-based compounds of Formula 1A or 1B.

The organic light-emitting device, which includes the organic layer including the at least one of the carbazole-based compound of Formula 1A or 1B, may have a low driving voltage, a high efficiency, a high luminance, and a long lifetime.

The carbazole-based compound of Formula 1A or 1B may be used between a pair of electrodes of an organic light-emitting device, For example, the carbazole-based compound of Formula 1A or 1B may be included in at least one of the emission layer, a hole transport region between the first electrode and the emission layer (for example, including at least one of a hole injection layer, a hole transport layer, and an electron blocking layer), and an electron transport region between the emission layer and the second electrode (for example, including at least one of a hole blocking layer, an electron transport layer, and an electron injection layer). For example, the carbazole-based compound of Formula 1A or 1B may be included in the emission layer. In this regard, the emission layer may further include a dopant, and the carbazole-based compound of Formula 1A or 1B in the emission layer may serve as a host. The emission layer may be a blue emission layer emitting blue light, or a green emission layer emitting green light. The dopant may be a phosphorescent dopant.

As used herein, “(for example, the organic layer) including at least one of the carbazole-based compounds means that “(the organic layer) including one of the carbazole-based compounds of Formula 1A or 1B, or at least two different carbazole-based compounds of Formula 1A or 1B”.

In some embodiments, the organic layer may include only Compound 1 above as the carbazole-based compound of Formula 1A or 1B. Compound 1 may be situated in the emission layer of the organic light-emitting device. In some embodiments, the organic layer may include Compounds 1 and 2 as the carbazole-based compound of Formula 1A or 1B. In this regard, Compounds 1 and 2 may be present in the same layer (for example, in the emission layer) or may be present in different layers.

For example, the first electrode may be an anode as a hole injection electrode, and the second electrode may be a cathode as an electron injection electrode, or vice versa. That is, the first electrode may be a cathode as an electron injection electrode, and the second electrode may be an anode as a hole injection electrode.

For example, the first electrode may be an anode, the second electrode may be a cathode, and the organic layer may include

i) a hole transport region disposed between the first electrode and the emission layer and including at least one of a hole injection layer, a hole transport layer, and an electron blocking layer; and

ii) an electron transport region disposed between the emission layer and the second electrode and including at least one of a hole blocking layer, an electron transport layer, and an electron injection layer.

The term “organic layer” as used herein refers to a single layer and/or a plurality of layers disposed between the first and second electrodes of the organic light-emitting device. The “organic layer” may include an organic compound, and/or an organometallic complex including a metal.

FIG. 1 is a schematic view of an organic light-emitting device 10 according to an embodiment of the present disclosure. Hereinafter, a structure of an organic light-emitting device according to an embodiment of the present disclosure and a method of manufacturing the same will now be described with reference to FIG. 1. Referring to FIG. 1, the organic light-emitting device 10 has a structure in which a substrate 11, a first electrode 11, an organic layer 15, and a second electrode 19 are sequentially stacked in this order.

A substrate (not shown) may be disposed under the first electrode 11 or on the second electrode 190 in FIG. 1. The substrate may be any substrate that is used in conventional organic light emitting devices. In some embodiments the substrate may be a glass substrate or a transparent plastic substrate with strong mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and water resistance.

The first electrode 11 may be formed by depositing or sputtering a first electrode-forming material on the substrate 11. The first electrode 11 may be an anode. A material having a high work function may be selected as a material for the first electrode to facilitate hole injection. The first electrode 11 may be a reflective electrode, a semi-transmissive electrode, or a transmissive electrode. For example, the material for the first electrode 13 may be indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO₂), or zinc oxide (ZnO). In some embodiments, the material for the first electrode 13 may be metals, for example, magnesium (Mg), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), magnesium-silver (Mg—Ag), or the like.

The first electrode 11 may have a single-layer structure or a multi-layer structure including at least two layers.

The organic layer 15 may be disposed on the first electrode 11.

The organic layer 15 may include a hole transport region; an EMI, and an electron transport region.

The hole transport region may be disposed between the first electrode 11 and the EML.

The hole transport region may include at least one of a hole injection layer (HIL), a hole transport layer (HTL), an electron blocking layer (EBL), and a buffer layer.

The hole transport region may include exclusively the HIL or the HTL. In some embodiments, the electron transport region may have a structure including a HIL/HTL or a HIL/HTL/EBL, wherein the layers forming the structure of the electron transport region may be sequentially stacked on the first electrode 10 in the stated order.

When the hole transport region includes the HIL, the HIL may be formed on the first electrode 11 by any of a variety of methods, for example, vacuum deposition, spin coating, casting, Langmuir-Blodgett (LB) deposition, or the like.

When the HIL is formed using vacuum deposition, vacuum deposition conditions may vary depending on the material that is used to form the HIL, and the desired structure and thermal properties of the HIL to be formed. For example, vacuum deposition may be performed at a temperature of about 100° C. to about 500° C., a pressure of about 10⁻⁸torr to about 10⁻³torr, and a deposition rate of about 0.01 to about 100 Å/sec. However, the deposition conditions are not limited thereto.

When the HIL is formed using spin coating, the coating conditions may vary depending on the material that is used to form the HIL, and the desired structure and thermal properties of the HIL to be formed. For example, the coating rate may be in the range of about 2,000 revolutions per minute (rpm) to about 5,000 rpm, and a temperature at which heat treatment is performed to remove a solvent after coating may be in a range of about 80° C. to about 200° C. However, the coating conditions are not limited thereto.

Conditions for forming the HTL and the EBL may be the same as those for the HIL described above.

In some embodiments, the hole transport region may include at least one of m-MTDATA, TDATA, 2-TNATA, NPB, β-NPB, TPD, Spiro-TPD, Spiro-NPB, α-NPB, TAPC, HMTPD, 4,4′,4″-tris(N-carbazolyl)triphenylamine (TCTA), polyaniline/dodecylbenzene sulfonic acid (Pani/DBSA), poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate)(PEDOT/PSS), polyaniline/camphor sulfonic acid (Pani/CSA), polyaniline/poly(4-styrenesulfonate) (PANI/PSS), a compound represented by Formula 201 below, and a compound represented by Formula 202 below.

embedded image

In Formula 201 above, Ar₁₀₁and Ar₁₀₂may be each independently selected from:

a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an acenaphthylene group, a fluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, and a pentacenylene group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₂-C₁₀heterocycloalkyl group, a C₂-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₂-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group.

In Formula 201, xa and xb may be each independently an integer from 0 to 5, for example, may be 0, 1, or 2. For example, xa may be 1, and xb may be 0, but are not limited thereto.

In Formulae 201 and 202, R₁₀₁to R₁₀₈, R₁₁₁to R₁₁₉, and R₁₂₁to R₁₂₄may be each independently one of:

a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₁₀alkyl group (for example, a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, or the like), and a C₁-C₁₀alkoxy group (for example, a methoxy group, an ethoxy group, a propoxy group, a butoxy group, a pentoxy group, or the like),

a C₁-C₁₀alkyl group and a C₁-C₁₀alkoxy group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, and a phosphoric acid group or a salt thereof,

a phenyl group, a naphthyl group, an anthracenyl group, a fluorenyl group, and a pyrenyl group, and

a phenyl group, a naphthyl group, an anthracenyl group, a fluorenyl group, and a pyrenyl group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₁₀alkyl group, and a C₁-C₁₀alkoxy group. However, embodiments of the present disclosure are not limited thereto.

In Formula 201 above, R₁₀₉may be one of:

a phenyl group, a naphthyl group, an anthracenyl group, and a pyridinyl group, and

a phenyl group, a naphthyl group, an anthracenyl group, and a pyridinyl group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, and a C₁-C₂₀alkoxy group.

In some embodiments, the compound of Formula 201 may be represented by Formula 201A, but is not limited thereto:

embedded image

In Formula 201A, R₁₀₁, R₁₁₁, R₁₁₂, and R₁₀₉may be the same as those defined above.

For example, the compound of Formula 201 and the compound of Formula 202 may include Compounds HT1 to HT20 below, but are not limited thereto:

embedded image

A thickness of the hole transport region may be from about 100 Angstrom (Å) to about 10,000 Å, and in some embodiments, from about 100 Å to about 1,000 Å. When the hole transport region includes a HIL and a HTL, a thickness of the HIL may be from about 100 Å to about 10,000 Å, and in some embodiments, from about 100 Å to about 1,000 Å, and a thickness of the HTL may be from about 50 Å to about 2,000 Å, and in some embodiments, from about 100 Å to about 1,500 Å. When the thicknesses of the hole transport region, the HIL, and the HTL are within these ranges, satisfactory hole transport characteristics may be obtained without a substantial increase in driving voltage.

The hole transport region may further include a charge-generating material to improve conductivity, in addition to the materials as described above. The charge-generating material may be homogeneously or non-homogeneously dispersed in the hole transport region.

The charge-generating material may be, for example, a p-dopant. The p-dopant may be one of a quinine derivative, a metal oxide, and a cyano group-containing compound, but is not limited thereto. Non-limiting examples of the p-dopant are quinone derivatives such as tetracyanoquinonedimethane (TCNQ), 2,3,5,6-tetrafluoro-tetracyano-1,4-benzoquinonedimethane (F4-TCNQ), and the like; metal oxides such as tungsten oxide, molybdenum oxide, and the like; and cyano-containing compounds such as Compound 200 below.

embedded image

The hole transport region may further include a buffer layer.

The buffer layer may compensate for an optical resonance distance of light according to a wavelength of the light emitted from the EML, and thus may increase efficiency.

The EML may be formed on the hole transport region by using vacuum deposition, spin coating, casting, LB deposition, or the like. When the EML is formed using vacuum deposition or spin coating, the conditions for deposition and coating may be similar to those for the formation of the HIL, though the conditions for the deposition and coating may vary depending on the material that is used to form the EML.

The EML may include a host and a dopant. The host may include at least one of the carbazole-based compounds represented by Formula 1A or 1B above.

The host may further include at least one of TPBi, TBADN, ADN (also referred to as “DNA”), CBP, CDBP, and TCP, in addition to the carbazole-based compound of Formula 1A or 1B:

embedded image

When the organic light-emitting device is a full color organic light-emitting device, the emission layer may be patterned into a red emission layer, a green emission layer, and a blue emission layer. In some embodiments, the EML may have a stack structure including a red emission layer, a green emission layer, and/or a blue emission layer that are stacked upon one another to emit white light, but is not limited thereto. A host of at least one of the red emission layer, the green emission layer, and the blue emission layer may include the carbazole-based compounds of Formula 1A or 1B. For example, the host of the green emission layer may include the carbazole-based compounds of Formula 1A or 1B.

The EML of the light-emitting device may include a dopant, which may be a fluorescent dopant emitting light based on fluorescence mechanism, or a phosphorescent dopant emitting light based on phosphorescence mechanism.

In some embodiments, the EML may include a host including the carbazole-based compounds of Formula 1A or 1B, and a phosphorescent dopant. The phosphorescent dopant may include an organometallic complex including a transition metal, for example, iridium (Ir), platinum (Pt), osmium (Os), or rhodium (Rh).

For example, the phosphorescent dopant may include an organometallic compound represented by Formula 81 below, but is not limited thereto:

embedded image

In Formula 81,

M may be iridium (Ir), platinum (Pt), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), or thulium (Tm);

Y₁to Y₄may be each independently a carbon (C) or a nitrogen (N);

Y₁and Y₂may be linked to each other via a single bond or a double bond, and Y₃and Y₄may be linked to each other via a single bond or a double bond;

CY₁and CY₂may be each independently a benzene, a naphthalene, a fluorene, a spiro-fluorene, an indene, a pyrrole, a thiophene, a furan, an imidazole, a pyrazole, a thiazole, an isothiazole, an oxazole, an isooxazole, a pyridine, a pyrazine, a pyrimidine, a pyridazine, a quinoline, an isoquinoline, a benzoquinoline, a quinoxaline, a quinazoline, a carbazole, a benzoimidazole, a benzofuran, a benzothiophene, an isobenzothiophene, a benzooxazole, an isobenzooxazole, a triazole, a tetrazole, an oxadiazole, a triazine, a dibenzofuran, or a dibenzothiophene, wherein CY₁and CY₂may be optionally linked to each other via a single bond or an organic linking group;

R₈₁and R₈₂may be each independently a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, —SF₅, a substituted or unsubstituted C₁-C₆₀alkyl group, a substituted or unsubstituted C₂-C₆₀alkenyl group, a substituted or unsubstituted C₂-C₆₀alkynyl group, a substituted or unsubstituted C₁-C₆₀alkoxy group, a substituted or unsubstituted C₃-C₁₀cycloalkyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₂-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₆-C₆₀aryloxy group, a substituted or unsubstituted C₆-C₆₀arylthio group, a substituted or unsubstituted C₂-C₆₀heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group, —N(Q₁)(Q₂), —Si(Q₃)(Q₄)(Q₅), or —B(Q₆)(Q₇);

a81 and a82 may be each independently an integer selected from 1 to 5;

n81 may be an integer selected from 0 to 4;

n82 may be 1, 2, or 3;

L₈₁may be a monovalent organic ligand, a divalent organic ligand, or a trivalent organic ligand.

Substituents R₈₁and R₈₂in Formula 81 are the same as described above with reference to R₁.

The phosphorescent dopant may include at least one of Compounds PD1 to PD74, but is not limited thereto:

embedded image

Compound PD 1 is Ir(ppy)₃.

In some embodiments, the phosphorescent dopant may include PtOEP or Compound PhGD represented below:

embedded image

In some other embodiments, the phosphorescent dopant may include at least one of DPAVBi, BDAVBi, TBPe, DCM, DCJTB, Coumarin 6, and C545T represented below.

embedded image

When the EML includes both a host and a dopant, the amount of the dopant may be from about 0.01 to about 15 parts by weight based on 100 parts by weight of the host. However, the amount of the dopant is not limited to this range.

The thickness of the EML may be about 100 Å to about 1,000 Å, and in some embodiments, may be from about 200 Å to about 600 Å. When the thickness of the EML is within these ranges, the EML may have improved light emitting ability without a substantial increase in driving voltage.

Next, the electron transport region may be disposed on the EML.

The electron transport region may include at least one of a HBL, an ETL, and an EIL.

In some embodiments, the electron transport region may have a structure including a HBL/ETL/EIL or a ETL/EIL, wherein the layers forming the structure of the electron transport region may be sequentially stacked on the EML in the stated order. However, embodiments of the present disclosure are not limited thereto. The ETL may have a single-layer structure or a multi-layer structure including at least two different layers.

Conditions for forming the HBL, ETL, and EIL of the electron transport region may be defined based on the above-described formation conditions for the HIL.

When the electron transport region includes the HBL, the HBL may include at least one of BCP, Bphen, BAlq represented below. However, embodiments of the present disclosure are not limited thereto.

embedded image

A thickness of the HBL may be from about 20 Å to about 1,000 Å, and in some embodiments, from about 30 Å to about 300 Å. When the thickness of the HBL is within these ranges, the HBL may have improved hole blocking ability without a substantial increase in driving voltage.

The ETL may further include at least one of Alq₃, Balq, TAZ, and NTAZ below, in addition to BCP and Bphen described above.

embedded image

In some embodiments, the ETL may include at least one of Compounds ET1 and ET2 represented below, but is not limited thereto.

embedded image

A thickness of the ETL may be from about 100 Å to about 1,000 Å, and in some embodiments, from about 150 Å to about 500 Å. When the thickness of the ETL is within these ranges, the ETL may have satisfactory electron transporting ability without a substantial increase in driving voltage.

In some embodiments the ETL may further include a metal-containing material, in addition to the above-described materials.

The metal-containing material may include a lithium (Li) complex. Non-limiting examples of the Li complex are compound ET-D1 below (lithium quinolate (LiQ)), or compound ET-D2 below.

embedded image

The electron transport region may include an EIL that may facilitate injection of electrons from the second electrode 19. The EIL may include at least one selected from LiF, NaCl, CsF, Li₂O, and BaO. The thickness of the EIL may be from about 1 Å to about 100 Å, and in some embodiments, from about 3 Å to about 90 Å. When the thickness of the EIL is within these ranges, the EIL may have satisfactory electron injection ability without a substantial increase in driving voltage.

The second electrode 19 is disposed on the organic layer 15. The second electrode 19 may be a cathode. A material for the second electrode 19 may be a metal, an alloy, or an electrically conductive compound that have a low work function, or a combination thereof. Non-limiting examples of the material for the second electrode 19 are lithium (Li), magnesium (Mg), aluminum (Al), aluminum (Al)-lithium (Li), calcium (Ca), magnesium (Mg)-indium (In), and magnesium (Mg)-silver (Ag), or the like. In some embodiments, to manufacture a top-emission light-emitting device, the second electrode 19 may be formed as a transmissive electrode from, for example, indium tin oxide (ITO) or indium zinc oxide (IZO).

Although the organic light-emitting device of FIG. 1 is described above, embodiments of the present disclosure are not limited thereto.

As used herein, a C₁-C₆₀alkyl group refers to a linear or branched aliphatic hydrocarbon monovalent group having 1 to 60 carbon atoms. Non-limiting examples of the C₁-C₆₀alkyl group a methyl group, an ethyl group, a propyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl group, an iso-amyl group, and a hexyl group. A C₁-C₆₀alkylene group refers to a divalent group having the same structure as the C₁-C₆₀alkyl.

As used herein, a C₁-C₆₀alkoxy group refers to a monovalent group represented by —OA₁₀₁(where A₁₀₁is a C₁-C₆₀alkyl group as described above. Non-limiting examples of the C₁-C₆₀alkoxy group are a methoxy group, an ethoxy group, and an isopropyloxy group.

As used herein, a C₂-C₆₀alkenyl group refers to a structure including at least one carbon double bond in the middle or at the terminal of the C₂-C₆₀alkyl group. Non-limiting examples of the C₂-C₆₀alkenyl group are an ethenyl group, a propenyl group, and a butenyl group. A C₂-C₆₀alkylene group refers to a divalent group having the same structure as the C₂-C₆₀alkenyl group.

As used herein, a C₂-C₆₀alkynyl group refers to a structure including at least one carbon triple bond in the middle or at the terminal of the C₂-C₆₀alkyl group. Non-limiting examples of the C₂-C₆₀alkynyl group are an ethynyl group and a propynyl group. A C₂-C₆₀alkynylene group used herein refers to a divalent group having the same structure as the C₂-C₆₀alkynyl group.

As used herein, a C₃-C₁₀cycloalkyl group refers to a monovalent, monocyclic hydrocarbon group having 3 to 10 carbon atoms. Non-limiting examples of the C₃-C₁₀cycloalkyl group are a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group. A C₃-C₁₀cycloalkylene group refers to a divalent group having the same structure as the C₃-C₁₀cycloalkyl group.

As used herein, a C₂-C₁₀heterocycloalkyl group refers to a monovalent monocyclic group having 2 to 10 carbon atoms in which at least one hetero atom selected from N, O, P, and S is included as a ring-forming atom. Non-limiting examples of the C₂-C₁₀heterocycloalkyl group are a tetrahydrofuranyl group and a tetrahydrothiophenyl group. A C₂-C₁₀heterocycloalkylene group refers to a divalent group having the same structure as the C₂-C₁₀heterocycloalkyl group.

As used herein, a C₃-C₁₀cycloalkenyl group refers to a monovalent monocyclic group having 3 to 10 carbon atoms that includes at least one double bond in the ring but does not have aromaticity. Non-limiting examples of the C₃-C₁₀cycloalkenyl group are a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group. A C₃-C₁₀cycloalkenylene group refers to a divalent group having the same structure as the C₃-C₁₀cycloalkenyl group.

As used herein, a C₂-C₁₀heterocycloalkenyl group used herein refers to a monovalent monocyclic group having 2 to 10 carbon atoms that includes at least one double bond in the ring and in which at least one hetero atom selected from N, O, P, and S is included as a ring-forming atom. Non-limiting examples of the C₂-C₁₀heterocycloalkenyl group are a 2,3-dihydrofuranyl group and a 2,3-dihydrothiophenyl group. A C₂-C₁₀heterocycloalkenylene group used herein refers to a divalent group having the same structure as the C₃-C₁₀heterocycloalkenyl group.

As used herein, a C₆-C₆₀aryl group refers to a monovalent, aromatic carbocyclic aromatic group having 6 to 60 carbon atoms, and a C₆-C₆₀arylene group refers to a divalent, aromatic carbocyclic group having 6 to 60 carbon atoms. Non-limiting examples of the C₆-C₆₀aryl group are a phenyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, and a chrysenyl group. When the C₆-C₆₀aryl group and the C₆-C₆₀arylene group include at least two rings, the rings may be fused to each other.

As used herein, a C₂-C₆₀heteroaryl group refers to a monovalent, aromatic carbocyclic aromatic group having 2 to 60 carbon atoms in which at least one hetero atom selected from N, O, P, and S is included as a ring-forming atom, and 2 to 60 carbon atoms. A C₂-C₆₀heteroarylene group refers to a divalent, aromatic carbocyclic group having 2 to 60 carbon atoms in which at least one hetero atom selected from N, O, P, and S is included as a ring-forming atom. Non-limiting examples of the C₂-C₆₀heteroaryl group are a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, and an isoquinolinyl group. When the C₂-C₆₀heteroaryl and the C₂-C₆₀heteroarylene include at least two rings, the rings may be fused to each other.

As used herein, a C₆-C₆₀aryloxy group indicates —OA₁₀₂(where A₁₀₂is a C₆-C₆₀aryl group as described above), and a C₆-C₆₀arylthio group indicates —SA₁₀₃(where A₁₀₃is a C₆-C₆₀aryl group as described above).

As used herein, a monovalent non-aromatic condensed polycyclic group refers to a monovalent group having at least two rings condensed to each other, in which only carbon atoms (for example, 8 to 60 carbon atoms) are exclusively included as ring-forming atoms, and wherein the entire molecule is non-aromatic. A non-limiting example of the monovalent non-aromatic condensed polycyclic group is a fluorenyl group. A divalent non-aromatic condensed polycyclic group refers to a divalent group having the same structure as the monovalent non-aromatic condensed polycyclic group.

As used herein, a monovalent non-aromatic condensed heteropolycyclic group refers to a monovalent group having at least two rings condensed to each other, in which both carbon atoms (for example, 8 to 60 carbon atoms) and heteroatoms are included as ring-forming atoms, and wherein the entire molecule is non-aromatic. A non-limiting example of the monovalent non-aromatic condensed heteropolycyclic group is a carbazolyl group. A divalent non-aromatic condensed heteropolycyclic group refers to a divalent group having the same structure as the monovalent non-aromatic condensed heteropolycyclic group.

As used herein, at least one substituent of the substituted C₃-C₁₀cycloalkenylene group, the substituted C₂-C₁₀heterocycloalkenylene group, the substituted C₆-C₆₀arylene group, the substituted C₂-C₆₀heteroarylene group, the substituted divalent nonaromatic condensed polycyclic group, the substituted divalent nonaromatic condensed heteropolycyclic group, the substituted C₁-C₆₀alkyl group, the substituted C₂-C₆₀alkenyl group, the substituted C₂-C₆₀alkynyl group, the substituted C₃-C₁₀cycloalkyl group, the substituted C₂-C₁₀heterocycloalkyl group, the substituted C₃-C₁₀cycloalkenyl group, the substituted C₂-C₁₀heterocycloalkenyl group, the substituted C₆-C₆₀aryl group, the substituted C₆-C₆₀aryloxy group, the substituted C₆-C₆₀arylthio group, the substituted C₂-C₆₀heteroaryl group, the substituted monovalent nonaromatic condensed polycyclic group, and the substituted monovalent nonaromatic condensed heteropolycyclic group may be selected from:

a C₃-C₁₀cycloalkyl group, a C₂-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₂-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₂-C₆₀heteroaryl group, a monovalent nonaromatic condensed polycyclic group, and a monovalent nonaromatic condensed heteropolycyclic group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, and a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₂-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₂-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₂-C₆₀heteroaryl group, a monovalent nonaromatic condensed polycyclic group, a monovalent nonaromatic condensed heteropolycyclic group, —Si(Q₂₁)(Q₂₂)(Q₂₃), and —B(Q₂₄)(Q₂₅), and

—Si(Q₃₁)(Q₃₂)(Q₃₃), and —B(Q₃₄)(Q₃₅),

wherein Q₁to Q₅, Q₁₁to Q₁₅, Q₂₁to Q₂₅, and Q₃₁to Q₃₅are each independently selected from a hydrogen, C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₂-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₂-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₂-C₆₀heteroaryl group, a monovalent nonaromatic condensed polycyclic group, and a monovalent nonaromatic condensed heteropolycyclic group.

For example, at least one substituent of the substituted C₃-C₁₀cycloalkenylene group, the substituted C₂-C₁₀heterocycloalkenylene group, the substituted C₆-C₆₀arylene group, the substituted C₂-C₆₀heteroarylene group, the substituted divalent nonaromatic condensed polycyclic group, the substituted divalent nonaromatic condensed heteropolycyclic group, the substituted C₁-C₆₀alkyl group, the substituted C₂-C₆₀alkenyl group, the substituted C₂-C₆₀alkynyl group, the substituted C₃-C₁₀cycloalkyl group, the substituted C₂-C₁₀heterocycloalkyl group, the substituted C₃-C₁₀cycloalkenyl group, the substituted C₂-C₁₀heterocycloalkenyl group, the substituted C₆-C₆₀aryl group, the substituted C₆-C₆₀aryloxy group, the substituted C₆-C₆₀arylthio group, the substituted C₂-C₆₀heteroaryl group, the substituted monovalent nonaromatic condensed polycyclic group, and the substituted monovalent nonaromatic condensed heteropolycyclic group may be selected from:

a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, and a C₁-C₆₀alkoxy group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyrimidinyl group, an imidazopyridinyl group, —Si(Q₁₁)(Q₁₂)(Q₁₃), and —B(Q₁₄)(Q₁₅,

a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyrimidinyl group, and an imidazopyridinyl group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, and a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₂-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₂-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₂-C₆₀heteroaryl group, a monovalent nonaromatic condensed polycyclic group, a monovalent nonaromatic condensed heteropolycyclic group, —Si(Q₂₁)(Q₂₂)(Q₂₃), and —B(Q₂₄)(Q₂₅), and

—Si(Q₃₁)(Q₃₂)(Q₃₃), and —B(Q₃₄)(Q₃₅),

wherein Q₁to Q₅, Q₁₁to Q₁₅, Q₂₁to Q₂₅, and Q₃₁to Q₃₅are each independently selected from a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyrimidinyl group, and an imidazopyridinyl group, each substituted with at least one of from a hydrogen, C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group. However, embodiments of the present disclosure are not limited thereto.

One or more embodiments of the present disclosure, which include condensed cyclic compounds, and organic light-emitting devices including the same, will now be described in detail with reference to the following examples. However, these examples are only for illustrative purposes and are not intended to limit the scope of the one or more embodiments of the present disclosure. In the following synthesis example, the expression that “‘B’ instead of ‘A’ was used” means that the amounts of ‘B’ and ‘A’ were the same in equivalent amounts.

EXAMPLES
Synthesis Example 1
Synthesis of Compound 1

embedded image

Synthesis of Intermediate A

After 20.1 g (61.8 mmol) of 3-iodo-4-nitro-1,1′-biphenyl, 18.6 g (92.7 mmol) of 2-bromophenyl)boronic acid, 2.4 g (9.2 mmol) of triphenylphosphine (PPh₃), 0.7 g (3.1 mmol) of tetrakis(triphenylphosphine)palladium(0) (Pd(PPh₃)₄), and 17.1 g (123.7 mmol) of potassium carbonate (K₂CO₃) were put into a 2-necked flask, 800 mL of toluene and 80 mL of H₂O were added thereto, followed by purging with argon and reflux for about 12 hours. The reaction product was cooled down to room temperature, followed by extraction with ethyl acetate (EA). An organic layer was collected, dried using magnesium sulfate (MgSO₄), and purified using column chromatography (hexane/EA=10/1) to obtain Intermediate A (47 g, Yield: 75%).

¹H NMR (CDCl₃, 300 MHz): 8.22 (d, 1H), 7.78 (dd, 1H), 7.70˜7.64 (m, 3H), 7.56 (d, 1H), 7.52˜7.39 (m, 4H), 7.33˜7.26 (m, 2H).

Synthesis of Intermediate B

After 25.8 g (72.9 mmol) of Intermediate A and 57.4 g (218.8 mmol) of PPh₃were put into a 1-necked flask, 80 mL of 1,2-dichlorobenzene (DCB) was added thereto, followed by purging with argon and stirring at about 150° C. for about 12 hours. After removing DCB by distillation, the resulting product was cooled down to room temperature, dissolved in a small amount of toluene, and purified using column chromatography (hexane) to obtain Intermediate B (15 g, Yield: 64%).

¹H NMR (CDCl₃, 300 MHz): 8.99 (s, 1H), 8.20 (b, 1H), 7.75˜7.72 (m, 3H), 7.51˜7.46 (m, 3H), 7.43˜7.27 (m, 4H).

Synthesis of Intermediate C

After 32.0 g (99.3 mmol) of Intermediate B, 0.63 g (9.9 mmole) of Cu, and 27.1 g (198.6 mmol) of K₂CO₃were put into a 2-necked flask, 320 mL of dimethylformamide (DMF) was added thereto, followed by purging with argon and addition of 22.5 mL (198.6 mmol) of iodobenzene. The resulting product was refluxed for about 12 hours, and cooled down to room temperature, followed by extraction with EA. An organic layer was collected, dried using magnesium sulfate (MgSO₄), and purified using column chromatography (hexane) to obtain Intermediate C in white solid form (25 g, Yield: 64%). Intermediate C was identified using ¹H-nuclear magnetic resonance (NMR) and liquid chromatography-mass spectrometry (LC/MS).

¹H NMR (CDCl₃, 300 MHz): 9.07 (d, 1H), 7.75˜7.71 (m, 3H), 7.69˜7.61 (m, 2H), 7.55˜7.40 (m, 7H), 7.37˜7.31 (m, 2H), 7.26˜7.22 (dd, 1H)

LC/MS, calcd.: C₂₄H₁₆BrN=398.29. found: m/z=398.1 (M+, 100%)

Synthesis of Intermediate D

After 33 g (83 mmol) of Intermediate C, 25 g (100 mmol) of 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane), 21 g (210 mmol) of potassium acetate (KOAc), and 3.4 g (4.2 mmol) of 1,1′-bis(diphenylphosphino)ferrocene-palladium(II)dichloride (PdCl₂(dppf)₂) were put into a 2-necked flask, and 200 mL of tetrahydrofuran (THF) was added thereto and stirred at about 70° C. for about 24 hours. After completion of the reaction, the reaction solution was extracted with water and EA. An organic layer was collected, dried using magnesium sulfate (MgSO₄), and purified using column chromatography (methylene chloride/n-hexane=3/2, Silica gel) to obtain Intermediate D in white solid form (26 g, Yield: 60%).

¹H NMR (CDCl₃, 300 MHz): 9.52 (s, 1H), 7.79˜7.32 (m, 15H), 1.50 (s, 12H).

Synthesis of Compound 1

13.3 g (30 mmol) of Intermediate D, 7.3 g (27 mmol) of 2-chloro-4,6-diphenyl-1,3,5-triazine, 11 g (81 mmol) of K₂CO₃, and 1.5 g (1.3 mmol) of Pd(PPh₃)₄were added to 50 mL of toluene and stirred at about 120° C. for about 24 hours. After completion of the reaction, water was added to the reaction product and stirred, followed by filtration to obtain a dark gray solid. This solid was dissolved in hot toluene, and then filtered. The resulting toluene solution was collected, and methanol was added thereto to obtain a precipitate. This precipitate was filtered to obtain a solid, which was then recrystallized with 1-chlorobenzene to obtain Compound 1 in yellow crystal form (11.0 g, Yield: 73%). Compound 1 was identified using LC/MS.

LC/MS, calcd.: C₃₉H₂₆N₄=550.65. found: m/z=550.2 (M+, 100%)

Synthesis Example 2
Synthesis of Compound 2

embedded image

Compound 2 (yellow crystal, Yield: 67%) was synthesized in the same manner as in the synthesis of Compound 1 of Synthesis Example 1, except that 2-chloro-4,6-diphenylpyrimidine, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine, was used.

Compound 2 was identified using LC/MS.

LC/MS, calcd.: C₄₀H₂₇N₃=549.66. found: m/z=549.2 (M+, 100%)

Synthesis Example 3
Synthesis of Compound 3

embedded image

17.5 g (42 mmol) of Intermediate C, 20.0 g (46 mmol) of 2,4-diphenyl-6-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,5-triazine, 14 g (104 mmol) of K₂CO₃, and 2.4 g (2.1 mmol) of Pd(PPh₃)₄were added to 80 mL of toluene and stirred at about 120° C. for about 48 hours. After completion of the reaction, water was added to the reaction product and stirred, followed by filtration to obtain a dark gray solid. This solid was dissolved in hot toluene, and then filtered. The resulting toluene solution was collected, and methanol was added thereto to obtain a precipitate. This precipitate was filtered to obtain a solid, which was then recrystallized with 1-chlorobenzene to obtain Compound 3 in white powder (18.0 g, Yield: 70%). Compound 3 was identified using 1H-NMR and LC/MS.

¹H NMR (CDCl₃, 300 MHz): 9.17 (s, 1H), 8.92 (d, 1H), 8.77 (dd, 4H), 7.95˜7.68 (m, 7H), 7.66˜7.40 (m, 14H), 7.27˜7.19 (m, 3H).

LC/MS, calcd.: C₄₅H₃₀N₄=626.75. found: m/z=626.2 (M+, 100%)

Synthesis Example 4
Synthesis of Compound 18

embedded image

Compound 18 (white solid, Yield: 76%) was synthesized in the same manner as in the synthesis of Compound 1 of Synthesis Example 1, except that 2-(3′-bromo-[1,1′-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine, was used. Compound 18 was identified using LC/MS.

LC/MS, calcd.: C₅₁H₃₄N₄=702.84. found: m/z=702.2 (M+, 100%)

Synthesis Example 5
Synthesis of Compound 32

embedded image

Synthesis of Intermediate E

Intermediate E (white solid, Yield: 66%) was synthesized in the same manner as in the synthesis of Intermediate A of Synthesis Example 1, except that 3-bromo-[1,1′-biphenyl]-4-yl)boronic acid, instead of (2-bromophenyl)boronic acid, was used. Intermediate E was identified using LC/MS.

LC/MS, calcd.: C₂₄H₁₆BrNO₂=430.29. found: m/z=429.04 (M+, 100%)

Synthesis of Intermediate F

Intermediate F (white solid, Yield: 57%) was synthesized in the same manner as in the synthesis of Intermediate B of Synthesis Example 1, except that Intermediate E, instead of Intermediate A, was used. Intermediate F was identified using LC/MS.

LC/MS, calcd.: C₂₄H₁₆BrN=398.29. found: m/z=397.05 (M+, 100%)

Synthesis of Intermediate G

Intermediate G (white solid, Yield: 61%) was synthesized in the same manner as in the synthesis of Intermediate C of Synthesis Example 1, except that Intermediate F, instead of Intermediate B, was used. Intermediate G was identified using LC/MS.

LC/MS, calcd.: C₃₀H₂₀BrN=474.39. found: m/z=475.08 (M+, 100%)

Synthesis of Compound 32

Compound 32 (white solid, Yield: 70%) was synthesized in the same manner as in the synthesis of Compound 3 of Synthesis Example 3, except that Intermediate G, instead of Intermediate C, was used. Compound 32 was identified using LC/MS.

LC/MS, calcd.: C₅₁H₃₄N₄=702.84. found: m/z=702.28 (M+, 100%)

Synthesis Example 6
Synthesis of Compound 36

embedded image

Synthesis of Intermediate H

Intermediate H (white solid, Yield: 50%) was synthesized in the same manner as in the synthesis of Intermediate C of Synthesis Example 1, except that 2-bromotriphenylene, instead of iodobenzene, was used. Intermediate H was identified using LC/MS.

LC/MS, calcd.: C₃₆H₂₂BrN=548.47. found: m/z=547.09 (M+, 100%)

Synthesis of Compound 36

Compound 36 (white solid, Yield: 52%) was synthesized in the same manner as in the synthesis of Compound 3 of Synthesis Example 3, except that Intermediate H, instead of Intermediate C, was used. Compound 36 was identified using LC/MS.

LC/MS, calcd.: C₅₇H₃₆N₄=776.92. found: m/z=776.29 (M+, 100%)

Synthesis Example 7
Synthesis of Compound 39

embedded image

Synthesis of Intermediate I

Intermediate I (yellow solid, Yield: 54%) was synthesized in the same manner as in the synthesis of Intermediate A of Synthesis Example 1, except that 2-(3-iodo-4-nitrophenyl)triphenylene, instead of 3-iodo-4-nitro-1,1′-biphenyl, was used. Intermediate L was identified using LC/MS.

LC/MS, calcd.: C₃₀H₁₈BrNO₂=504.37. found: m/z=503.05 (M+, 100%)

Synthesis of Intermediate J

Intermediate J (white solid, Yield: 48%) was synthesized in the same manner as in the synthesis of Intermediate B of Synthesis Example 1, except that Intermediate I, instead of Intermediate A, was used. Intermediate J was identified using LC/MS.

LC/MS, calcd.: C₃₀H₁₈BrN=472.37. found: m/z=471.06 (M+, 100%)

Synthesis of Intermediate K

Intermediate K (white solid, Yield: 45%) was synthesized in the same manner as in the synthesis of Intermediate C of Synthesis Example 1, except that Intermediate J, instead of Intermediate B, was used. Intermediate K was identified using LC/MS.

LC/MS, calcd.: C₃₆H₂₂BrN=548.47. found: m/z=547.09 (M+, 100%)

Synthesis of Compound 39

Compound 39 (white solid, Yield: 63%) was synthesized in the same manner as in the synthesis of Compound 3 of Synthesis Example 3, except that Intermediate K, instead of Intermediate C, was used. Compound 39 was identified using LC/MS.

LC/MS, calcd.: C₅₇H₃₆N₄=779.92. found: m/z=776.29 (M+, 100%)

Synthesis Example 8
Synthesis of Compound 96

embedded image

Synthesis of Intermediate L

Intermediate L (white solid, Yield: 60%) was synthesized in the same manner as in the synthesis of Intermediate A of Synthesis Example 1, except that 9-(3-iodo-4-nitrophenyl)-9H-carbazole, instead of 3-iodo-4-nitro-1,1′-biphenyl, was used.

Intermediate L was identified using LC/MS.

LC/MS, calcd.: C₂₄H₁₅N₂O₂=443.29. found: m/z=442.0 (M+, 100%)

Synthesis of Intermediate M

Intermediate M (white solid, Yield: 55%) was synthesized in the same manner as in the synthesis of Intermediate B of Synthesis Example 1, except that Intermediate L, instead of Intermediate A, was used. Intermediate M was identified using LC/MS.LC/MS, calcd.: C₂₄H₁₅BrN₂=411.29. found: m/z=410.0 (M+, 100%)

Synthesis of Intermediate N

Intermediate N (white solid, Yield: 62%) was synthesized in the same manner as in the synthesis of Intermediate C of Synthesis Example 1, except that Intermediate M, instead of Intermediate B, was used. Intermediate N was identified using LC/MS.

LC/MS, calcd.: C₃₀H₁₉BrN₂=487.39. found: m/z=486.0 (M+, 100%)

Synthesis of Compound 96

Compound 96 (white solid, Yield: 68%) was synthesized in the same manner as in the synthesis of Compound 3 of Synthesis Example 3 via recrystallization with n-methyl-2-pyrrolidone (NMP), except that Intermediate N, instead of Intermediate C, was used. Compound 96 was identified using LC/MS.

LC/MS, calcd.: C₅₁H₃₃N₅=715.84. found: m/z=715.2 (M+, 100%)

Evaluation Example 1
Evaluation of HOMO, LUMO, and Triplet (T₁) Energy Levels and Energy Band Gap

The highest occupied molecular orbital (HOMO), lowest unoccupied molecular orbital (LUMO), and triplet (T₁) energy levels of Compounds 1, 2, 3, 18, 32, 36, 39, 96, and C were evaluated according to the methods described in Table 1 below. The results are shown in Table 2.

TABLE 1

HOMO energy level
HOMO energy levels of the compounds were

evaluation method
evaluated using a density functional theory

(DFT) method (B3LYP/6-31G(D,P)//B3LYP/

6-31G(D,P) w/Gaussian09)

LUMO energy level
LUMO energy levels of the compounds were

evaluation method
evaluated using a DFT method

(B3LYP/6-31G(D,P)//B3LYP/6-31G(D,P)

w/Gaussian09)

T1 energy level
T1 energy levels of the compounds were evaluated

evaluation method
using a time dependent density

functional theory (TDDFT) method

(B3LYP/6-31G(D,P)//B3LYP/6-31G(D,P)

w/Gaussian09)

TABLE 2

LUMO (eV)

Energy

Compound
HOMO (eV)
(Absolute
T1 energy
band

No.
(Absolute value)
value)
level (eV)
gap (eV)

Compound 1
5.234
1.790
2.612
3.453

Compound 2
5.108
1.619
2.710
3.489

Compound 3
5.195
1.820
2.877
3.375

Compound 18
5.220
1.813
2.958
3.375

Compound 32
5.215
1.826
2.808
3.389

Compound 36
5.179
1.821
2.792
3.358

Compound 39
5.164
1.848
2.749
3.316

Compound 96
5.054
1.809
2.799
3.245

Compound C
5.384
1.925
2.666
3.459

embedded image

Referring to Table 1, Compound 1, 2, 3, 18, 32, 36, 39, and 96 were found to have high T1 energy levels and wide band gaps, and thus have electrically characteristics suitable for use as materials for organic light-emitting devices.

The absolute values of the HOMO and LUMO energy levels of Compound 1, 2, 3, 18, 32, 36, 39, and 96 are smaller than those of Compound C, indicating that Compound 1, 2, 3, 18, 32, 36, 39, and 96 have electrical characteristics suitable for use as materials of organic light-emitting devices.

Example 1

To manufacture an anode, a glass substrate with deposited ITO/Ag/ITO layers (70 Å/1,000 Å/70 Å) was cut to a size of 50 mm×50 mm×0.5 mm and then ultrasonicated in isopropyl alcohol and pure water each for five minutes, and then cleaned by irradiation of ultraviolet rays for 30 minutes and exposure to ozone. The resulting glass substrate was loaded into a vacuum deposition device.

2-TNATA was deposited on the anode to form an HIL having a thickness of 60 nm, and then NPB was deposited on the HIL to form a HTL having a thickness of 100 nm.

Compound 1 (host) and Ir(ppy)₃(dopant) were co-deposited in a weight ratio of about 91:9 on the HTL to form an EML having a thickness of about 25 nm, followed by depositing BCP on the EML to form a HBL having a thickness of about 5 nm. After deposition of Alq₃on the HBL to form an ETL having a thickness of about 35 nm, LiF was deposited on the ETL to form an EIL having a thickness of about 1 nm, followed by co-depositing Mg and Ag in a weight ratio of 9:1 on the EIL to form a cathode having a thickness of about 12 nm, thereby completing the manufacture of the organic light-emitting device (emitting green light).

Example 2

An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 2, instead of Compound 1, was used as a host to form the EML.

Example 3

An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 3, instead of Compound 1, was used as a host to form the EML.

Example 4

An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 18, instead of Compound 1, was used as a host to form the EML.

Example 5

An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 32, instead of Compound 1, was used as a host to form the EML.

Example 6

An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 36, instead of Compound 1, was used as a host to form the EML.

Example 7

An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 39, instead of Compound 1, was used as a host to form the EML.

Example 8

An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 96, instead of Compound 1, was used as a host to form the EML.

Comparative Example A

An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound A, instead of Compound 1, was used as a host to form the EML.

embedded image

Comparative Example B

An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound B, instead of Compound 1, was used as a host to form the EML.

embedded image

Comparative Example C

An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound C, instead of Compound 1, was used as a host to form the EML.

embedded image

Evaluation Example 3
Characteristics Evaluation of Organic Light-Emitting Devices

Current density changes with respect to voltage, luminance changes, and emission efficiencies in the organic light-emitting devices of Examples 1 to 8 and Comparative Examples A, B, and C were measured according to the following methods. The results are shown in Table 3 below.

1) Color coordinates were measured using a PR650 (Spectroscan) Source Measurement Unit (available from Photo Research, Inc.) with a supply of power using a Kethley Source-Measure Unit (SMU 236).

2) Luminances were measured using a PR650 (Spectroscan) Source Measurement Unit (available from Photo Research, Inc.) with a supply of power using a Kethley Source-Measure Unit (SMU 236).

3) Efficiencies were measured using a PR650 (Spectroscan) Source Measurement Unit (available from Photo Research, Inc.) with a supply of power using a Kethley Source-Measure Unit (SMU 236).

4) Lifetime (LT97) was measured as the time taken until an initial luminance (assumed as 100%) measured at a current density of about 10 milliamperes per square centimeter (mA/cm²) is reduced to 97%.

TABLE 3

Color

Driving voltage
Efficiency
Luminance
L97
coordinates

Example
Host
(V)
(cd/A)
(cd/m²)
(hr)
CIE x
CIE y

Example 1
Compound 1
3.7
91
9000
120
0.25
0.71

Example 2
Compound 2
3.8
90
9000
130
0.24
0.71

Example 3
Compound 3
3.6
115
9000
359
0.25
0.71

Example 4
Compound 18
3.6
109
9000
245
0.25
0.71

Example 6
Compound 32
3.6
110
9000
105
0.26
0.71

Example 7
Compound 36
3.5
105
9000
280
0.25
0.70

Example 8
Compound 39
3.7
102
9000
210
0.26
0.70

Example 10
Compound 96
3.8
120
9000
365
0.24
0.71

Comparative
Compound A
3.8
80
9000
75
0.26
0.70

Example A

Comparative
Compound B
4.1
65
9000
12
0.29
0.71

Example B

Comparative
Compound C
3.9
76
9000
50
0.25
0.71

Example C

Referring to Table 3, the organic light-emitting devices of Examples 1 to 8 were found to have improved emission efficiencies, compared to those of the organic light-emitting devices of Comparative Examples A to C. As described above, according to the one or more of the above embodiments of the present disclosure, a carbazole-based compound of Formula 1A or 1B may have good electrical characteristics and good thermal stability. An organic light-emitting device including the carbazole-based compound of Formula 1A or 1B may have a low driving voltage, a high efficiency, a high luminance, and long lifetime characteristics.

It should be understood that the exemplary embodiments described therein should be considered in a descriptive sense only and not for purposes of limitation. Descriptions of features or aspects within each embodiment should typically be considered as available for other similar features or aspects in other embodiments.

While one or more embodiments of the present disclosure have been described with reference to the figures, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the spirit and scope of the present disclosure as defined by the following claims.

Claims

1. A carbazole-based compound represented by Formula 1A or 1B:
2. The carbazole-based compound of claim 1, wherein the ring A is a C2-C20 heterocyclic group comprising at least three nitrogens as ring-forming atoms.
3. The carbazole-based compound of claim 1, wherein the ring A is selected from groups represented by Formulae 2-1 to 2-8:
4. The carbazole-based compound of claim 3, wherein at least one of R9a and R9b in Formula 2-1, at least one of R9a to R9c in Formulas 2-2 to 2-5, and 2-8, and at least one of R9a to R9e in Formulae 2-6, 2-7, and 2-9 to 2-16 are each independently selected from a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C2-C60 heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, and a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group.
5. The carbazole-based compound of claim 3, wherein the ring A in Formula 1A or 1B is a group represented by one of Formulae 2-1, 2-5, and 2-8.
6. The carbazole-based compound of claim 3, wherein the ring A in Formula 1A or 1B is a group represented by one of Formulae 2-1 to 2-4.
7. The carbazole-based compound of claim 1, wherein L1, L2, L11, and L12 are each independently selected from: a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-fluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pyrrolylene group, an imidazolylene group, a pyrazolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, an indazolylene group, a purinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a carbazolylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzooxazolylene group, a benzoimidazolylene group, a furanylene group, a benzofuranylene group, a thiophenylene group, a benzothiophenylene group, a thiazolylene group, an isothiazolylene group, a benzothiazolylene group, an isoxazolylene group, an oxazolylene group, a triazolylene group, a tetrazolylene group, an oxadiazolylene group, a triazinylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, an imidazopyrimidinylene group, and an imidazopyridinylene group,a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-fluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pyrrolylene group, an imidazolylene group, a pyrazolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, an indazolylene group, a purinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a carbazolylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzooxazolylene group, a benzoimidazolylene group, a furanylene group, a benzofuranylene group, a thiophenylene group, a benzothiophenylene group, a thiazolylene group, an isothiazolylene group, a benzothiazolylene group, an isoxazolylene group, an oxazolylene group, a triazolylene group, a tetrazolylene group, an oxadiazolylene group, a triazinylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, an imidazopyrimidinylene group, and an imidazopyridinylene group, each substituted with at least one of a deuterium atom, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a C6-C20 aryl group, and a C2-C60 heteroaryl group, andgroups represented by Formulae 3-1 to 3-6;
8. The carbazole-based compound of claim 1, wherein L1, L2, L11, and L12 are each independently selected from: a phenylene group, a naphthylene group, a phenalenylene group, a phenanthrenylene group, a triphenylenylene group, an anthracenylene group, a pyrrolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, a furanylene group, a benzofuranylene group, a thiophenylene group, a benzothiophenylene group, and a triazinylene group,a phenylene group, a naphthylene group, a phenalenylene group, a phenanthrenylene group, a triphenylenylene group, an anthracenylene group, a pyrrolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, a furanylene group, a benzofuranylene group, a thiophenylene group, a benzothiophenylene group, and a triazinylene group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a triphenylenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group, andgroups represented by Formulae 3-1 to 3-6;
9. The carbazole-based compound of claim 1, wherein a1, a2, a3, and a4 are each independently 0, 1, or 2.
10. The carbazole-based compound of claim 1, wherein R1 and R11 are each independently selected from a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group, and —Si(Q1)(Q2)(Q3); R2 to R9, and R12 to R18 are each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C1-C20 alkoxy group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C2-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C2-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group, and —Si(Q1)(Q2)(Q3);wherein at least one of R5 to R8 is selected from a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, a substituted or unsubstituted monovalent nonaromatic condensed polycyclic group, and a substituted or unsubstituted monovalent nonaromatic condensed heteropolycyclic group.
11. The carbazole-based compound of claim 1, wherein R1 to R9, and R11 to R18 are each independently selected from: a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, and a C1-C20 alkoxy group,a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a imidazopyrimidinyl group, and an imidazopyridinyl group,a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyrimidinyl group, and an imidazopyridinyl group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, a C2-C20 alkenyl group, a C2-C20 alkynyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group, and—Si(Q1)(Q2)(Q3);wherein at least one of R5 to R8 is selected from:a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyrimidinyl group, and an imidazopyridinyl group, anda phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyrimidinyl group, and an imidazopyridinyl group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, a C2-C20 alkenyl group, a C2-C20 alkynyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group;R1 and R11 are each independently selected from:a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyrimidinyl group, and an imidazopyridinyl group,a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzoxazolyl group, a benzoimidazolyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyrimidinyl group, and an imidazopyridinyl group, each substituted with at least one of a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, a C2-C20 alkenyl group, a C2-C20 alkynyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group, and—Si(Q1)(Q2)(Q3);wherein Q1 to Q3 are each independently selected from selected from a hydrogen, C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a triphenylenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group.
12. The carbazole-based compound of claim 1, wherein R1 and R11 are each independently selected from groups represented by Formulae 5-1 to 5-40, and —Si(Q1)(Q2)(Q3), wherein Q1 to Q3 are each independently selected from a hydrogen, C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a triphenylenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group; R2 to R4, and R12 to R14 are each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, and a C1-C20 alkoxy group;R5 to R9, and R15 to R18 are each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, and groups represented by Formulae 5-1 to 5-40;wherein at least one of R5 to R8, and at least one of R15 to R18 are each independently selected from groups represented by Formulae 5-1 to 5-40; andat least one of R9 is selected from groups represented by Formulae 5-1 to 5-40:
13. The carbazole-based compound of claim 1, wherein R1 to R8, and R11 to R18 are each independently selected from: a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, and a C1-C20 alkoxy group,a C1-C20 alkyl group and a C1-C20 alkoxy group, each substituted with at least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, and a phosphoric acid group or a salt thereof,a phenyl group, a naphthyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a phenanthrenyl group, a phenylenyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group,a phenyl group, a naphthyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a phenanthrenyl group, a phenylenyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a phenylenyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, and—Si(Q1)(Q2)(Q3), wherein Q1 to Q3 are each independently selected from a hydrogen, C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a triphenylenyl group, a fluorenyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a phthalazinyl group, a quinoxalinyl group, a cinnolinyl group, and a quinazolinyl group; andat least one of R5 to R8 is selected from:a phenyl group, a naphthyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a phenanthrenyl group, a phenylenyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, anda phenyl group, a naphthyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a phenanthrenyl group, a phenylenyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C20 alkyl group, a C1-C20 alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, a phenylenyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group.
14. The carbazole-based compound of claim 1, wherein the carbazole-based compound is represented by Formula 1A wherein a1 is 0;R1 is selected from Formulae 5-1 to 5-40;b1 is 0;R2 to R6 and R8 are a hydrogen;R7 is selected from Formulae 5-1 to 5-40; a2 is 0 or 1;L2 is selected from Formulae 4-1 to 4-15;ring A is represented Formula 2-1,wherein, in Formula 2-1, R9a and R9b are each independently, selected from Formulae 5-1 to 5-40:
15. The carbazole-based compound of claim 1, wherein the carbazole-based compound of Formula 1A or 1B is selected from Compounds 1 to 130:
16. An organic light-emitting device comprising: a first electrode;a second electrode; andan organic layer disposed between the first electrode and the second electrode,wherein the organic layer comprises an emission layer and at least one of the carbazole-based compounds of claim 1.
17. The organic light-emitting device of claim 16, wherein the first electrode is an anode,the second electrode is a cathode, andthe organic layer comprisesi) a hole transport region disposed between the first electrode and the emission layer and comprising at least one of a hole injection layer, a hole transport layer, and an electron blocking layer, andii) an electron transport region disposed between the emission layer and the second electrode and comprising at least one of a hole blocking layer, an electron transport layer, and an electron injection layer.
18. The organic light-emitting device of claim 16, wherein the emission layer comprises at least one of the carbazole-based compounds.
19. The organic light-emitting device of claim 18, wherein the emission layer further comprises a phosphorescent dopant, and the at least one of the carbazole-based compound serves as a host.
20. The organic light-emitting device of claim 18, wherein the emission layer further comprises a phosphorescent dopant, and the dopant comprises an organometallic compound represented by Formula 81: Formula 81

Priority Claims (1)

Number	Date	Country	Kind
10-2014-0015645	Feb 2014	KR	national

CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME

Information

Publication Number

Date Filed

Date Published

Inventors

Original Assignees

CPC

International Classifications

Abstract

Description

Claims

Priority Claims (1)